- SenderraRx’s management team will remain significant investors and continue to lead the company
- SenderraRx specializes in treating patients with complex and chronic conditions such as dermatology, rheumatology and oncology
- Will Howard serves as CEO and co-founder of SenderraRx
Nautic Partners has agreed to make a growth investment in SenderraRx, a Dallas-based specialty pharmacy.
